Building access to the Regenstrief Institute is restricted through early 2021. More on our coronavirus precautions.
See our coronavirus precautions.

Regenstrief Institute research scientist Noll Campbell, PharmD, M.S., recently contributed to a study that made national headlines and provided more evidence that anticholinergic medications are linked to cognitive decline.

The results from the study, led by researchers at the University of California San Diego School of Medicine, were published in Neurology. The authors concluded that anticholinergics are associated with an increased risk of cognitive decline regardless of the presence of genetic or biomarker risk factors for Alzheimer’s disease.

Dr. Campbell consulted on the study, providing perspective on the data based on similar studies he has been involved with at Regenstrief and Indiana University School of Medicine.  He is listed as an author on the paper.

The past research conducted by Dr. Campbell and his colleagues also provides evidence establishing a link between the common type of medication and cognitive decline. He is now leading a clinical trial to determine if deprescribing anticholinergics improves cognition, which could in turn delay or prevent dementia.

In addition to his role as a research scientist at Regenstrief Institute, Dr. Campbell is an assistant professor of pharmacy practice at the Purdue University College of Pharmacy.

Related Influence

Mar 15, 2021 • Influence
Regenstrief researcher explores benefits of mindfulness for cancer patients and survivors
Regenstrief Institute Research Scientist Shelley Johns, PsyD, is exploring the potential benefits of mindfulness practice for cancer patients and survivors through her research.   In March 2021, she published the most comprehensive and rigorous examination to-date of the existing evidence regarding mindfulness-based interventions for fatigue in cancer survivors. The analysis included 23 research papers from 21 independent randomized clinical trials. Results suggest that mindfulness interventions show promise in…
Continue Reading >
Feb 10, 2021 • Expert Opinion, Influence
Black History and Sam Regenstrief: Working for civil rights through health equity
Photo courtesy of Eskenazi Health By NiCole Keith, PhD, Regenstrief Institute Research Scientist February is the celebration of Black History Month, which began when Black Americans from all over the United States traveled to Washington, D.C., to commemorate the 50th anniversary of the Emancipation Proclamation that freed Black people from institutional servitude and to celebrate the contributions…
Continue Reading >